KATHLEEN LEJAMEYER: Open Payments
NPI 1710213558 · SPOKANE VALLEY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 37 payments from 11 companies in 2025. Trend: 2023 $796 · 2024 $1,150 · 2025 $915
Food & beverage: $843Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $303 |
| ABBVIE INC. | 10 | $257 |
| Lilly USA, LLC | 4 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| LEO Pharma Inc. | 3 | $62 |
| UCB, Inc. | 2 | $48 |
| Organon LLC | 2 | $30 |
| Amgen Inc. | 1 | $20 |
| Incyte Corporation | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: TREMFYA, RINVOQ, EBGLYSS, Bimzelx, DUPIXENT, ADBRY, LIBTAYO, BOTOX.
Industry payments across WA — which companies pay providers there.
